Patents for joint disease research

ELAN and Wyeth Pharmaceuticals have been issued seven patents for joint research into the prevention and treatment of Alzheimer’s disease.

Patents for joint disease research

These were issued to Neuralab, a subsidiary of Elan, by the United States Patent and Trademark office yesterday.

The news had a negative impact on the group’s shares that fell 60 cent to €19.22 as investors saw the announcement as a selling opportunity.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €120 €60

Best value

Monthly €10€5 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited